Classification of Dosage Forms according to the USP
The USP classification ("Taxonomie") of pharmaceutical dosage forms is presented in an article of the USP Pharmacopeial Forum 39 (3). The USP categorises 5 different dosage forms:
- Injections and implanted drug products (parenteral)
- Oral drug products
- Topical and transdermal drug products
- Mucosal drug products ( = dosage forms absorbed via the mucous membranes)
- Products for inhalation or nasal administration
The USP is currently elaborating a General Chapter for each of these 5 medicinal product groups. The fundamental requirements can already be found in Chapter <1151> on pharmaceutical dosage forms. Moreover, it is planned to create additional chapters about the 5 product groups mentioned above - if this has not been done yet - among other things also regarding the quality requirements on these products and the relevant "Performance Tests" which are essential for each dosage form.
The article "Product Quality and Product Performance General Chapters" in PF 39 (3) clearly describes the planned approach and the classification of the USP. The table at the end provides a good overview of each chapter and the current status of implementation.
More information can be found in the Pharmacopeial Forum.
Related GMP News
20.03.2025EMA Concept Paper on Model Informed Drug Development
20.03.2025End of the Transition Period for Clinical Trials
11.02.2025Final ICH E6(R3) Guideline on GCP released
11.02.2025FDA issues Draft Guidance on Handling Protocol Deviations in Clinical Trials
11.02.2025Further Progress in ICH's Global GMP Harmonization